In conclusion, further study regarding the mechanism of action of the RIZ1 tumor suppressor gene and the PR domain may reveal the underlying mechanism of anticancer function, and thus may lead to the development of novel biomarkers for early diagnosis and prognostic evaluation in ESCC. Here, PRDM2 is linked to esophageal squamous cell carcinoma.